LOS ANGELES- Red Light Holland Corp., a production and distribution of functional mushrooms and psilocybin truffles, has announced the successful initial testing and dehydration of psilocybin truffles at CCrest Laboratories Inc. in Montreal, Canada. This development marks a significant step in the company’s expansion into psychedelic research and product development.
On April 8th, 2024, Red Light Holland initiated its largest shipment to date, sending 5 kg of freshly cultivated psilocybin truffles from the Netherlands to CCrest Labs. This process, enabled by a Health Canada approved import permit, underscores the rigorous standards and international cooperation characterizing this venture.
CCrest Labs, a cGMP-certified pharmaceutical laboratory, has meticulously completed the dehydration and baseline testing of the psychoactive substances, psilocybin and psilocin, in the truffles. Following this, the dehydrated truffles have been sent to PharmAla Biotech Holdings Inc.’s laboratory, Chiral Labs, for further extraction and research. This extraction aims to refine and stabilize psilocybin for longer shelf life and potential clinical research applications.
Todd Shapiro, CEO and Director of Red Light Holland, expressed enthusiasm about the progress, highlighting the transition to a crucial extraction phase with PharmAla as pivotal for exploring the therapeutic potential of psilocybin and scaling up natural-source Active Pharmaceutical Ingredients (API) production.
Red Light Holland is committed to advancing psychedelic research and keeping its stakeholders informed about ongoing developments and outcomes from this collaborative effort.
